<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Nuveen Preferred And Income Etf — News on 6ix</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf</link>
<description>Latest news and press releases for Nuveen Preferred And Income Etf on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 13 Mar 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/nuveen-preferred-and-income-etf" rel="self" type="application/rss+xml" />
<item>
<title>Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/purple-biotech-reports-fourth-quarter-and-full-year-2025-financial-results-24</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/purple-biotech-reports-fourth-quarter-and-full-year-2025-financial-results-24</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second tri-specific</description>
</item>
<item>
<title>Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/aditxt-acquires-ignite-proteomics-to-address-a-critical-challenge-in-cancer-care-optimizing-therapy-selection-11</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/aditxt-acquires-ignite-proteomics-to-address-a-critical-challenge-in-cancer-care-optimizing-therapy-selection-11</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Ignite plans to launch a new program in 2026 supporting treatment selection for more than 600,000 people in the United States living with metastatic cancer</description>
</item>
<item>
<title>Mach Natural Resources LP 2025 Schedule K-1 Tax Packages for Common Units Now Available</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/mach-natural-resources-lp-2025-schedule-k-1-tax-packages-for-common-units-now-available-7</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/mach-natural-resources-lp-2025-schedule-k-1-tax-packages-for-common-units-now-available-7</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>OKLAHOMA CITY--(BUSINESS WIRE)-- Mach Natural Resources LP (NYSE: MNR) (“Mach” or the “Company”) today announced that the Company’s tax packages for the year</description>
</item>
<item>
<title>Purple Biotech Announces CEO Transition</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/purple-biotech-announces-ceo-transition-27</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/purple-biotech-announces-ceo-transition-27</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development REHOVOT, Israel, March 13, 2026 (GLOBE</description>
</item>
<item>
<title>BitFuFu to Report Full Year 2025 Financial Results on March 20, 2026</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/bitfufu-to-report-full-year-2025-financial-results-on-march-20-2026-15</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/bitfufu-to-report-full-year-2025-financial-results-on-march-20-2026-15</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>SINGAPORE, March 13, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc., (“BitFuFu” or “the Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services</description>
</item>
<item>
<title>WeRide Inc. Announces Results of Extraordinary General Meeting, Class A Meeting and Class B Meeting</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/weride-inc-announces-results-of-extraordinary-general-meeting-class-a-meeting-and-class-b-meeting-11</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/weride-inc-announces-results-of-extraordinary-general-meeting-class-a-meeting-and-class-b-meeting-11</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEx: 0800), a global leader in autonomous driving</description>
</item>
<item>
<title>SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/sbc-medical-to-announce-q4-and-fullyear-2025-financial-results-23</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/sbc-medical-to-announce-q4-and-fullyear-2025-financial-results-23</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management</description>
</item>
<item>
<title>Sky Gold Engages Drill Company for Upcoming Program on Its Evening Star Property, Walker Lane Trend, Nevada</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/sky-gold-engages-drill-company-for-upcoming-program-on-its-evening-star-property-walker-lane-trend-nevada-6</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/sky-gold-engages-drill-company-for-upcoming-program-on-its-evening-star-property-walker-lane-trend-nevada-6</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Highlights:Preparing to drill test the one-kilometer diameter magnetic body with overlapping gravity and concentric IP anomalies at the High Life copper-gold</description>
</item>
<item>
<title>Ladder Capital Corp Announces First Quarter 2026 Dividend to Holders of Class A Common Stock</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/ladder-capital-corp-announces-first-quarter-2026-dividend-to-holders-of-class-a-common-stock-16</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/ladder-capital-corp-announces-first-quarter-2026-dividend-to-holders-of-class-a-common-stock-16</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>NEW YORK--(BUSINESS WIRE)-- Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors of a first</description>
</item>
<item>
<title>Western Alliance Bank Launches Healthcare Industry Specialization, Led by Industry Veteran Jennifer Hwang</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/western-alliance-bank-launches-healthcare-industry-specialization-led-by-industry-veteran-jennifer-hwang-7</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/western-alliance-bank-launches-healthcare-industry-specialization-led-by-industry-veteran-jennifer-hwang-7</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Specialized commercial and industrial banking team tailors solutions to companies across the healthcare sector PHOENIX--(BUSINESS WIRE)-- Western Alliance</description>
</item>
<item>
<title>P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/p3-health-partners-schedules-fourth-quarter-and-full-year-2025-earnings-release-and-conference-call-21</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/p3-health-partners-schedules-fourth-quarter-and-full-year-2025-earnings-release-and-conference-call-21</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>HENDERSON, Nev.--(BUSINESS WIRE)-- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health</description>
</item>
<item>
<title>Hello, Cincinnati: CAVA’s Expansion Into the Midwest Continues</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/hello-cincinnati-cavas-expansion-into-the-midwest-continues-8</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/hello-cincinnati-cavas-expansion-into-the-midwest-continues-8</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>The growing Mediterranean concept brings bold flavors and nutritious meals to its first Cincinnati location in Oakley Station WASHINGTON--(BUSINESS WIRE)--</description>
</item>
<item>
<title>Activate Energy Acquisition Corp. Announces Filing of Annual Report for Year Ended December 31, 2025</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/activate-energy-acquisition-corp-announces-filing-of-annual-report-for-year-ended-december-31-2025-9</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/activate-energy-acquisition-corp-announces-filing-of-annual-report-for-year-ended-december-31-2025-9</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>GRAND CAYMAN, Cayman Islands, March 13, 2026 (GLOBE NEWSWIRE) -- Activate Energy Acquisition Corp. (NASDAQ: AEAQ) (the “Company”), a special purpose</description>
</item>
<item>
<title>Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/barinthus-bio-reports-full-year-2025-financial-results-and-updates-on-corporate-developments-26</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/barinthus-bio-reports-full-year-2025-financial-results-and-updates-on-corporate-developments-26</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to create a differentiated company focusing on clinical metabolic and autoimmune pipeline</description>
</item>
<item>
<title>GrafTech Announces Filing of Trade Petition with the Government of Brazil Regarding Unfairly Priced Graphite Electrode Imports</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/graftech-announces-filing-of-trade-petition-with-the-government-of-brazil-regarding-unfairly-priced-graphite-electrode-imports-6</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/graftech-announces-filing-of-trade-petition-with-the-government-of-brazil-regarding-unfairly-priced-graphite-electrode-imports-6</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) ("GrafTech," the "Company," "we," or "our"), a leading manufacturer of</description>
</item>
<item>
<title>SAIC Board of Directors Declares Cash Dividend</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/saic-board-of-directors-declares-cash-dividend-10</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/saic-board-of-directors-declares-cash-dividend-10</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>RESTON, Va., March 13, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors</description>
</item>
<item>
<title>Southern Energy Renewables and Axens Sign Memorandum of Understanding to Advance SAF Projects in Louisiana and Beyond</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/southern-energy-renewables-and-axens-sign-memorandum-of-understanding-to-advance-saf-projects-in-louisiana-and-beyond</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/southern-energy-renewables-and-axens-sign-memorandum-of-understanding-to-advance-saf-projects-in-louisiana-and-beyond</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Global technology licensor to provide complete SAF and CO₂ capture suite; collaboration supports development roadmap for Southern Energy Renewables NEW</description>
</item>
<item>
<title>Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/zentek-ltd-receives-favorable-judgment-in-long-standing-litigation-6</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/zentek-ltd-receives-favorable-judgment-in-long-standing-litigation-6</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Ontario Superior Court Dismisses Claims Originally Exceeding $6 Million Against Zentek GUELPH, ON / ACCESS Newswire / March 13, 2026 / Zentek Ltd.</description>
</item>
<item>
<title>YY Group Welcomes The Landmark Bangkok to Growing Hospitality Client Portfolio</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/yy-group-welcomes-the-landmark-bangkok-to-growing-hospitality-client-portfolio-3</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/yy-group-welcomes-the-landmark-bangkok-to-growing-hospitality-client-portfolio-3</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>New Manpower Outsourcing Contract Advances Subsidiary YY Circle Thailand's Path to Meaningful Scale, Adds to 2026 Revenue VisibilitySINGAPORE, March 13, 2026</description>
</item>
<item>
<title>Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update</title>
<link>https://6ix.com/company/nuveen-preferred-and-income-etf/news/savara-reports-fourth-quarter-and-year-end-2025-financial-results-and-provides-business-update-20</link>
<guid isPermaLink="true">https://6ix.com/company/nuveen-preferred-and-income-etf/news/savara-reports-fourth-quarter-and-year-end-2025-financial-results-and-provides-business-update-20</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Achieved Regulatory Milestones for the MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Development Program: U.S. Food and Drug</description>
</item>
</channel>
</rss>